on
October 29, 2026
US Health Secretary RFK Jr to expand access to unapproved peptides
Health experts have cautioned against use of the drugs, citing a lack of clinical trials for humans and the unknown long-term effects.
on
October 28, 2026
Peptide peddlers cheer as RFK Jr. unilaterally grants access, overruling FDA
Six unproven peptides popular with MAHA now under "enforcement discretion policy."
on
October 28, 2026
FDA scientists opposed Trump administration’s move to ease peptide access
Effort to loosen rules on unproven peptide drugs, favored by RFK Jr, faced fierce pushback from agency scientistsA plan to give people in the United States easier access to unproven peptide drugs favored by the US health secretary, Robert F Kennedy Jr,…
on
October 16, 2026
RFK Jr. proposes FDA look the other way on unproven peptides, report says
FDA scientists said none of the popular drugs have been proven safe or effective.